A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Solid Tumor
Interventions: DRUG: GNC-035
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Collaborators: SystImmune Inc.